A Phase III Study of SYHA1813 for Recurrent or Progressive High-Grade Meningiomas
Clinical trial NCT07613450 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07613450
- Sponsor
- Shanghai Runshi Pharmaceutical Technology Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-20
- Primary completion
- 2029-07-31
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.